Exploring new treatments for lung cancer
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
This study is exploring new and exciting treatments for lung cancer, like targeted therapies and vaccines, to help patients find better options for their care, thanks to the teamwork of several top hospitals connected to Harvard.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10891392 on NIH RePORTER |
What this research studies
This research focuses on advancing the understanding and treatment of lung cancer through a collaborative effort among multiple prestigious Harvard-affiliated hospitals. The program aims to develop innovative therapies, including targeted treatments and vaccines, by leveraging insights from previous successful research in the field. Patients may benefit from new therapeutic options that arise from this comprehensive approach to lung cancer treatment, which includes both basic and clinical research methodologies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with lung cancer, particularly those with advanced stages of the disease.
Not a fit: Patients with early-stage lung cancer or those who do not have a diagnosis of lung cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and potentially improved outcomes for lung cancer patients.
How similar studies have performed: Previous research in lung cancer has shown significant success in developing targeted therapies, indicating a strong potential for breakthroughs in this ongoing research.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Barbie, David a — Dana-Farber Cancer Inst
- Study coordinator: Barbie, David a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.